Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Evotec SE
EVO

Buy Evotec SE (EVO) Stock

EVO
See EVO stock price and Buy/Sell Evotec SE with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
EVO

Evotec SE (EVO)

About Evotec SE (EVO)

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which ...Read more
Market Cap
$4.73B
1 Year High
$26.57
Volume
40.23k
1 Year Low
$10.60
Price to Earnings Ratio
214.26
Open
$13.22
Dividend Rate
High
$13.23
Dividend Yield
Low
$13.01

Community

People who own or watch EVO stock

Evotec SE Stock News

Evotec SE stock rating

What analysts recommend for EVO stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
1.8

Evotec SE price target

What analysts think EVO will be worth
Low $10.60
High $66.79
Current $13.07
Target $66.79

Evotec SE earnings

The value each share was expected to gain vs. the value that each share actually gained
1.88
0.96
0.05
-0.87
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022

Expected EPS
Q3 2022
$0.21
Actual EPS
Q3 2022

Buy Evotec SE (EVO) Stock

EVO
See EVO stock price and Buy/Sell Evotec SE with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch EVO stock
  • whitneyrn avatar
  • Gmoney40 avatar
  • dollymeg88 avatar
  • MalikBirdie avatar
  • 1Dar avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.